India Reports 10 Percent Increase In Drug Sales Last Year
This article was originally published in PharmAsia News
Executive Summary
Pharmaceutical sales in India increased by 10 percent last year to register $697.34 million. But the increase, which came as drug makers continued to cut back on marketing costs, was not as large as 2007's 13.4 percent. November and December months recorded increased sales after October sales registered the year's first decline. The growth in global sales, by comparison, saw a greater decline, down from 11.4 percent in 2007 to 3.6 percent in the 2008 year ending in October. The top three sellers remained the same, Cipla, Ranbaxy Laboratories and GlaxoSmithKline in that order. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.